George D. Yancopoulos

Jan 26, 2024 | healio.com | Kristen Dowd |Marc E. Rothenberg |George D. Yancopoulos

Marc E. Rothenberg, MD, PhD The approval of dupilumab for children starting at age 1 year is an amazing advance for patients and families suffering from EoE. The scientific basis for using dupilumab for EoE is based in part by research conducted by my laboratory. I am grateful to the CURED Foundation and NIH and others for their long-term financial support, which provided critical funds that were leveraged for the basic research that led to this important advancement.